MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
2.040
-0.010
-0.49%
After Hours: 2.040 0 0.00% 16:05 05/09 EDT
OPEN
2.110
PREV CLOSE
2.050
HIGH
2.117
LOW
1.960
VOLUME
70.45K
TURNOVER
--
52 WEEK HIGH
6.01
52 WEEK LOW
1.100
MARKET CAP
35.14M
P/E (TTM)
-0.8642
1D
5D
1M
3M
1Y
5Y
1D
Psychedelic: Compass, GH Research, MindMed report quarterly earnings
TipRanks · 3d ago
NRx Pharmaceuticals (NASDAQ: NRXP) Files Patent for Preservative-Free Ketamine Formulation
TipRanks · 6d ago
NRX PHARMACEUTICALS INC - FILES PATENT APPLICATION FOR NRX-100
Reuters · 6d ago
Weekly Report: what happened at NRXP last week (0428-0502)?
Weekly Report · 6d ago
NRX Pharmaceuticals Price Target Maintained With a $31.00/Share by D. Boral Capital
Dow Jones · 04/30 18:30
NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital
Dow Jones · 04/30 18:30
NRx Pharmaceuticals awarded filing fee waiver by FDA for NRX-100 application
TipRanks · 04/30 13:27
NRx Pharma Announces Grant Of Filing Fee Waiver By FDA To Exempt NRx From $4.3M Fee To File New Drug Application For NRX-100
Benzinga · 04/30 12:49
More
About NRXP
More
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. The Company is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 is a combined NMDA/5-HT2A-targeted medicine designed to address both depression and suicidal ideation, consisting of an oral, fixed dose combination of DCS and lurasidone. Its NRX-100 is racemic ketamine, which is a generic anesthetic.
Recently
Symbol
Price
%Change

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.